PACIRA BIOSCIENCES INC (PCRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PCRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PCRX | Senior Advisor to BridgeBio Pharma, Inc.; and former Chief Executive Officer, Nodality, Inc.; Independent Board Chair; Independent Director | 67 | ["Over 35 years of leadership in pharmaceutical, biotechnology and venture capital", "Contributes to the board\u2019s oversight of strategic growth initiatives and capital allocation strategies", "Corporate governance experience gained through service on public company boards", "Proven track record in leading corporate functions and teams responsible for commercialization of drugs and treatments", "Brings substantial insights into business development and growth strategies", "CFO of COR Therapeutics, oversaw rapid growth to commercially launching a successful cardiovascular drug treatment"] | ["Audit", "People & Compensation", "Nominating, Governance & Sustainability", "Nominating", "Governance and Sustainability", "Nominating, Governance and Sustainability Committee"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MIRM | Senior Advisor | 68 | ["Over 20 years of executive management experience in the pharmaceutical, biotechnology and venture capital industries.","Former President and Chief Executive Officer of Nodality, Inc.","Held senior-level positions at Onyx Pharmaceuticals, Inc.","General Partner at Red Rock Capital Management.","Senior Vice President and Chief Financial Officer at COR Therapeutics Inc.","Chief Financial Officer at Flextronics, Inc."] | [] | 2026 |
| EWTX | DIRECTOR; Director; Chairperson | 68 | ["BridgeBio Pharma, Inc., Senior Advisor","Senior Advisor to BridgeBio Pharma, Inc.","Managing Director at Cervantes Life Science Partners, LLC","President and Chief Executive Officer at Nodality, Inc.","Executive Vice President and Chief Operating Officer at Onyx Pharmaceuticals, Inc.","General partner at Red Rock Capital Management","Senior Vice President and Chief Financial Officer at COR Therapeutics, Inc.","Vice President and Chief Financial Officer at Flextronics","Vice President and Treasurer of The Cooper Companies","Served on the boards of multiple biotechnology companies","audit committee financial expert","financial sophistication"] | ["Audit","Compensation"] | 2026 |
| ACAD | Director | 61 | [] | [] | 2019 |
Biography sourced from the proxy statement filing.
INDEPENDENT DIRECTOR since June 2011. CHAIR OF THE BOARD since January 2025. The Chair s responsibilities include: chairing the meetings of our board and stockholders; ensuring that our board works together as a cohesive team with open communication; ensuring that a process is in place by which the effectiveness of our board can be evaluated on a regular basis; monitoring communications from stockholders and other interested parties; otherwise consulting with management and the CEO on matters relating to corporate governance and board performance; working with the CEO on the board agenda and board materials; facilitating annual assessments of the performance of the board along with the Nominating, Governance and Sustainability Committee; acting as the primary internal spokesperson for our team with open communication; ensuring that management is aware of concerns of our board, the stockholders, other stakeholders, and the public; ensuring that management strategies, plans and performance are appropriately represented to our board; presiding at executive sessions of the non-employee directors; performing such other functions and responsibilities as requested by our board from time to time.